| | Variaz. | Variaz. 5g. | Variaz. 1 gen. | Variaz. 1anno | Variaz. 3anni | Capi. (M$) |
 | EMMAUS LIFE SCIENCES, INC. | -6.67% | 0.00% | -74.85% | -72.37% | --.--% | 21 |
| | | | | | | |
| MODERNA, INC. | 4.97% | 3.94% | -40.96% | -36.00% | 941.32% | 59 644 |
| IQVIA HOLDINGS INC. | -0.89% | 0.58% | -23.78% | -13.69% | 33.66% | 40 704 |
 | LONZA GROUP AG | 2.00% | 1.25% | -31.83% | -21.00% | 55.40% | 40 011 |
| SEAGEN INC. | 1.79% | 0.43% | 16.50% | 14.52% | 161.79% | 33 154 |
 | CELLTRION, INC. | 0.28% | 1.99% | -9.60% | -31.75% | -5.99% | 19 031 |
| ALNYLAM PHARMACEUTICALS, INC. | 1.65% | 0.51% | -12.58% | -13.52% | 103.17% | 17 911 |
| ICON PUBLIC LIMITED COMPANY | -1.84% | -3.59% | -31.32% | -1.10% | 37.76% | 17 292 |
 | PHARMARON BEIJING CO., LTD. | 0.55% | 0.87% | 1.66% | -36.08% | 304.42% | 16 158 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 0.74% | 6.94% | -9.78% | -43.62% | 123.88% | 14 188 |
| BIO-TECHNE CORPORATION | 1.89% | 0.12% | -31.73% | -21.44% | 65.39% | 13 856 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.27% | -3.31% | -41.92% | -41.52% | 54.78% | 11 118 |
| QIAGEN N.V. | 1.38% | 2.62% | -13.91% | -3.33% | 17.65% | 10 884 |
| UNITED THERAPEUTICS CORPORATION | 1.00% | -0.40% | 10.14% | 29.12% | 187.61% | 10 781 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | -0.27% | 1.06% | 5.44% | 45.63% | 237.69% | 10 323 |
 | GENSCRIPT BIOTECH CORPORATION | 1.61% | 4.79% | -17.54% | -16.08% | 45.01% | 7 657 |
| | | | | | | |
| | Media | 1.14% | 1.19% | -15.41% | -12.66% | 157.57% | |
| | Media ponderata per Capi. | 1.58% | 1.42% | -19.29% | -16.31% | 250.03% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
